157 related articles for article (PubMed ID: 32554846)
21. Circulating ANGPTL8/Betatrophin Concentrations Are Increased After Surgically Induced Weight Loss, but Not After Diet-Induced Weight Loss.
Pascual-Corrales E; Gómez-Ambrosi J; Moncada R; Valentí V; Catalán V; Rodríguez A; Ramírez B; Silva C; Gil MJ; Salvador J; Frühbeck G
Obes Surg; 2016 Aug; 26(8):1881-9. PubMed ID: 26768268
[TBL] [Abstract][Full Text] [Related]
22. Serum betatrophin levels are reduced in patients with full-blown polycystic ovary syndrome.
Eksi Haydardedeoglu F; Bagir GS; Haydardedeoglu B; Bozkirli E; Bakiner O; Metin K; Ertorer ME
Gynecol Endocrinol; 2019 Mar; 35(3):224-227. PubMed ID: 30241452
[TBL] [Abstract][Full Text] [Related]
23. Connective tissue growth factor (CTGF/CCN2) in serum is an indicator of fibrogenic progression and malignant transformation in patients with chronic hepatitis B infection.
Gressner OA; Fang M; Li H; Lu LG; Gressner AM; Gao CF
Clin Chim Acta; 2013 Jun; 421():126-31. PubMed ID: 23501329
[TBL] [Abstract][Full Text] [Related]
24. Relationship between serum betatrophin levels and the first-phase of glucose-stimulated insulin secretion.
Liu D; Qu H; Wang H; Duan Y; Liu F; Feng Z; Deng H
Obes Res Clin Pract; 2018; 12(Suppl 2):9-15. PubMed ID: 27554132
[TBL] [Abstract][Full Text] [Related]
25. Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease.
Newsome PN; Beldon I; Moussa Y; Delahooke TE; Poulopoulos G; Hayes PC; Plevris JN
Aliment Pharmacol Ther; 2000 Oct; 14(10):1295-301. PubMed ID: 11012474
[TBL] [Abstract][Full Text] [Related]
26. The Effects of Serum ANGPTL8/betatrophin on the Risk of Developing the Metabolic Syndrome - A Prospective Study.
Wang H; Lai Y; Han C; Liu A; Fan C; Wang H; Zhang H; Ding S; Teng W; Shan Z
Sci Rep; 2016 Jun; 6():28431. PubMed ID: 27345212
[TBL] [Abstract][Full Text] [Related]
27. Increased circulating full-length betatrophin levels in drug-naïve metabolic syndrome.
Liu D; Li S; He H; Yu C; Li X; Liang L; Chen Y; Li J; Li J; Sun X; Tian H; An Z
Oncotarget; 2017 Mar; 8(11):17510-17517. PubMed ID: 28177922
[TBL] [Abstract][Full Text] [Related]
28. Association between circulating microRNAs 486, 146b and 15b and serum betatrophin levels in obese; type 2 diabetic and non-diabetic children.
Mohany KM; Al Rugaie O; Al-Wutayd O; Al-Nafeesah A; Saleem TH
BMC Endocr Disord; 2020 Sep; 20(1):145. PubMed ID: 32988370
[TBL] [Abstract][Full Text] [Related]
29. Increased levels of irisin in people with long-standing Type 1 diabetes.
Espes D; Lau J; Carlsson PO
Diabet Med; 2015 Sep; 32(9):1172-6. PubMed ID: 25762196
[TBL] [Abstract][Full Text] [Related]
30. The Relationship between Circulating ANGPTL8/Betatrophin Concentrations and Adult Obesity: A Meta-Analysis.
Ye J; Qin Y; Wang D; Yang L; Yuan G
Dis Markers; 2019; 2019():5096860. PubMed ID: 31772689
[TBL] [Abstract][Full Text] [Related]
31. Elevation of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and carcinoma.
Yagmur E; Rizk M; Stanzel S; Hellerbrand C; Lammert F; Trautwein C; Wasmuth HE; Gressner AM
Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):755-61. PubMed ID: 17700260
[TBL] [Abstract][Full Text] [Related]
32. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
[TBL] [Abstract][Full Text] [Related]
33. A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease.
Gray J; Chattopadhyay D; Beale GS; Patman GL; Miele L; King BP; Stewart S; Hudson M; Day CP; Manas DM; Reeves HL
BMC Cancer; 2009 Aug; 9():271. PubMed ID: 19656391
[TBL] [Abstract][Full Text] [Related]
34. Plasma Betatrophin Levels and Carotid Atherosclerosis.
Niki H; Kishimoto Y; Saita E; Ohmori R; Kondo K; Momiyama Y
Dis Markers; 2019; 2019():4214650. PubMed ID: 31772685
[TBL] [Abstract][Full Text] [Related]
35. Serum Beta-2 Microglobulin: a Possible Marker for Disease Progression in Egyptian Patients with Chronic HCV Related Liver Diseases.
Ouda SM; Khairy AM; Sorour AE; Mikhail MN
Asian Pac J Cancer Prev; 2015; 16(17):7825-9. PubMed ID: 26625805
[TBL] [Abstract][Full Text] [Related]
36. Prognostic implication of serum vascular endothelial growth factor in advanced hepatocellular carcinoma staging.
Yegin EG; Siykhymbayev A; Eren F; Bekiroglu N; Ozdogan OC
Ann Hepatol; 2013; 12(6):915-25. PubMed ID: 24114822
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection.
Pompili M; Rapaccini GL; de Luca F; Caturelli E; Astone A; Siena DA; Villani MR; Grattagliano A; Cedrone A; Gasbarrini G
Cancer; 1997 Apr; 79(8):1501-8. PubMed ID: 9118030
[TBL] [Abstract][Full Text] [Related]
38. Irisin in Liver Cirrhosis.
Kukla M; Skladany L; Menżyk T; Derra A; Stygar D; Skonieczna M; Hudy D; Nabrdalik K; Gumprecht J; Marlicz W; Koulaouzidis A; Koller T
J Clin Med; 2020 Sep; 9(10):. PubMed ID: 33003490
[TBL] [Abstract][Full Text] [Related]
39. Vitamin B₁₂ and its binding proteins in hepatocellular carcinoma and chronic liver diseases.
Simonsen K; Rode A; Nicoll A; Villadsen G; Espelund U; Lim L; Angus P; Arachchi N; Vilstrup H; Nexo E; Grønbæk H
Scand J Gastroenterol; 2014 Sep; 49(9):1096-102. PubMed ID: 24958254
[TBL] [Abstract][Full Text] [Related]
40. Serum angiopoietin-2 level as a predictor of tumor invasiveness in patients with hepatocellular carcinoma.
Diaz-Sanchez A; Matilla A; Nuñez O; Lorente R; Fernandez A; Rincón D; Campos R; Bañares R; Clemente G
Scand J Gastroenterol; 2013 Mar; 48(3):334-43. PubMed ID: 23249262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
